This report contains market size and forecasts of Chronic Obstructive Pulmonary Disease Treatment in global, including the following market information:
Global Chronic Obstructive Pulmonary Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chronic Obstructive Pulmonary Disease Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Chronic Obstructive Pulmonary Disease Treatment companies in 2021 (%)
The global Chronic Obstructive Pulmonary Disease Treatment market was valued at 17830 million in 2021 and is projected to reach US$ 21710 million by 2028, at a CAGR of 2.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Umeclidinium Bromide and Vilanterol Trifenatate Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Obstructive Pulmonary Disease Treatment include GSK, Pfizer and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Obstructive Pulmonary Disease Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Obstructive Pulmonary Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chronic Obstructive Pulmonary Disease Treatment Market Segment Percentages, by Type, 2021 (%)
Umeclidinium Bromide and Vilanterol Trifenatate Powder
Pneumonia Vaccine
Global Chronic Obstructive Pulmonary Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chronic Obstructive Pulmonary Disease Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Chronic Obstructive Pulmonary Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chronic Obstructive Pulmonary Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Obstructive Pulmonary Disease Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chronic Obstructive Pulmonary Disease Treatment revenues share in global market, 2021 (%)
Key companies Chronic Obstructive Pulmonary Disease Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Chronic Obstructive Pulmonary Disease Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Pfizer
Merck